Evofem Biosciences (EVFM) News Today $0.0090 +0.00 (+1.12%) As of 04/17/2025 03:06 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Evofem Biosciences (NASDAQ:EVFM) Stock Passes Below 200-Day Moving Average - Should You Sell?April 17 at 3:43 AM | americanbankingnews.comEvofem Biosciences to Present at Emerging Growth ConferenceApril 14, 2025 | prnewswire.comEvofem Biosciences Inks Amendment with Windtree for PHEXXI SupplyApril 6, 2025 | investing.comEvofem Signs Sourcing Partnership With Windtree, Expects To Reduce Production Cost Of Phexxi By 60%March 28, 2025 | nasdaq.comEvofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree TherapeuticsMarch 26, 2025 | prnewswire.comEvofem Biosciences Reports Sales Growth and Strategic AdvancesMarch 25, 2025 | tipranks.comWindtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved ProductMarch 20, 2025 | globenewswire.comEvofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTOFebruary 13, 2025 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024November 16, 2024 | finanznachrichten.deEvofem Biosciences Reports Q3 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comAditxt announces Evofem secures voting agreements with investors for mergerNovember 6, 2024 | markets.businessinsider.comEvofem Secures Investor Support for Proposed Merger through Voting AgreementsNovember 6, 2024 | prnewswire.comEvofem Biosciences Faces Merger and Credit ChallengesNovember 1, 2024 | markets.businessinsider.comAditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with EvofemOctober 28, 2024 | finance.yahoo.comAditxt and Evofem partner to launch endometriosis diagnostic in 2025September 24, 2024 | msn.comEvofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by AditxtSeptember 24, 2024 | finance.yahoo.comAditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025September 20, 2024 | finance.yahoo.comInvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic TestSeptember 20, 2024 | msn.comAditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024September 9, 2024 | uk.finance.yahoo.comEvofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral SolutionAugust 20, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Second Quarter of 2024August 15, 2024 | finanznachrichten.deEvofem Biosciences Announces Financial Results for the Second Quarter of 2024August 14, 2024 | prnewswire.comEvofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stJuly 25, 2024 | globenewswire.comEvofem Signs Phexxi® License Agreement for Middle East with Pharma 1July 23, 2024 | prnewswire.comLupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSECJuly 15, 2024 | prnewswire.comHello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareJune 27, 2024 | prnewswire.comEvofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of MatterJune 11, 2024 | prnewswire.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024May 15, 2024 | investorplace.comEvofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | prnewswire.comEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTOApril 18, 2024 | prnewswire.comEvofem Biosciences, Inc. (EVFM)April 17, 2024 | finance.yahoo.comEvofem Biosciences, Inc. (EVFM) stock forecast and price targetApril 17, 2024 | finance.yahoo.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023March 27, 2024 | msn.comEvofem Reports $18.2 million of Phexxi Net Product Sales in 2023March 27, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-CalMarch 20, 2024 | finanznachrichten.deFor Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyMarch 7, 2024 | prnewswire.comEvofem Biosciences Stock (OTC:EVFM) Insider TradesFebruary 23, 2024 | benzinga.comEvofem Biosciences Stock (OTC:EVFM), Short Interest ReportFebruary 23, 2024 | benzinga.comEvofem Biosciences Inc (EVFM)February 13, 2024 | investing.comAditxt, Inc. Restructures Debt Post-Merger with EvofemFebruary 7, 2024 | markets.businessinsider.comEvofem Biosciences Announces Merger Agreement with AditxtFebruary 1, 2024 | msn.comEvofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3MFebruary 1, 2024 | msn.comEvofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023February 1, 2024 | finance.yahoo.comWashington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship GameJanuary 8, 2024 | finance.yahoo.comEvofem Biosciences Inc EVFMJanuary 3, 2024 | morningstar.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLIDecember 19, 2023 | markets.businessinsider.comEVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFMDecember 18, 2023 | businesswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EVFM, EARDecember 13, 2023 | markets.businessinsider.comEvofem just downgraded at Laidlaw, here's whyDecember 12, 2023 | realmoney.thestreet.com Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address EVFM Media Mentions By Week EVFM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVFM News Sentiment▼0.000.57▲Average Medical News Sentiment EVFM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVFM Articles This Week▼20▲EVFM Articles Average Week Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Avalon GloboCare News Sonnet BioTherapeutics News Oragenics News Dogwood Therapeutics News Kazia Therapeutics News Sonoma Pharmaceuticals News Clearmind Medicine News CNS Pharmaceuticals News Lixte Biotechnology News Creative Medical Technology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVFM) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVFM Stock Free EVFM Stock Alerts